Halozyme Therapeutics, Inc. · NASDAQ:HALO

Torley Helen sold 10,000 Halozyme Therapeutics, Inc. shares (Form 4)

Traded Apr 6, 2026 · Filed Apr 7, 2026

On Apr 6, 2026, Torley Helen (Director, PRESIDENT AND CEO) sold 10,000 Halozyme Therapeutics, Inc. shares at an average US$63.50 for US$635K under a trading plan, leaving 767,780 shares. Filed Apr 7, 2026 (Form 4).

Sold
10,000 shares
Price
US$63.50 average (US$63.14 to US$64.02)
Value
US$635K
Holding after
767,780 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, PRESIDENT AND CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockOption exercise10,000US$12.07777,780Direct
Apr 6, 2026Common StockSale5,900US$63.14771,880Direct
Apr 6, 2026Common StockSale4,100US$64.02767,780Direct

Source

View original at SEC

Related